調査レポートカテゴリー： MarketsandMarkets, 世界, 医療/バイオ

Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017

世界の神経調節市場：脊髄刺激、迷走神経刺激など

◆タイトル：Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017
◆商品コード：MD 1378
◆調査・発行会社：MarketsandMarkets
◆発行日：2013年1月
◆ページ数：193
◆レポート形式：pdf / 英語
◆納品方法：Eメール
◆調査対象地域：グローバル
◆販売価格オプション（消費税別）
Single userUSD5,650 ⇒換算￥610,200見積依頼/購入/質問フォーム
Multi User（～5名まで）USD6,650 ⇒換算￥718,200見積依頼/購入/質問フォーム
Corporate licence（社内共有可）USD8,150 ⇒換算￥880,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※商品の納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。（振込先：三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。（但し、対応範囲は弊社で判断）
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

 【レポートの概要】

本調査レポートでは、"世界の神経調節市場：脊髄刺激、迷走神経刺激など"について調査・分析し、イントロダクション、エグゼクティブサマリー、市場概観、市場の動態、地域別分析、市場規模及び予測、競争状況、市場シェア分析、新製品発売、主要企業（ベンダー）分析等の情報をお届けいたします。

Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market due to high demand for minimally invasive and non–invasive treatment. With advancements in technology, neuromodulation is expected to become a promising therapeutic area and high growth industry in the next decade, as it offers symptomatic relief mainly from chronic pain, incontinence, heart failure, headache, depression, epilepsy, etc. The neuromodulation devices market includes deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and others external stimulation devices such as transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation (TENS).

The neuromodulation technique acts directly upon nerves or the target area where the activity of nerves is altered due to biological responses produced by electrical stimulation or drug infusion. These devices include small electrodes that are attached to the brain, the spinal cord, or peripheral nerves. These precisely placed leads are connected by means of an extension cable to a pulse generator to generate electrical stimulation. Neuromodulation can have applications in any area of the body and can treat several diseases like chronic pain, epilepsy, psychiatric disorder, movement disorder, cardiovascular disorder, genitourinary and colorectal disorder, stroke and brain injury, and gastric disorder.

The main drivers for the neuromodulation market are the rising population of aged people and age-related diseases like Alzheimer’s, epilepsy, spinal cord injury, and Parkinson’s disease. According to the International Neuromodulation Society, about 40 million to 50 million patients worldwide suffer from epilepsy, and 1.5 million people currently (2012) suffer from Parkinson disease in the U.S. The large pool of patients that suffer from depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor offers the neuromodulation industry opportunities to grow in the next five years. The market for treatment of tinnitus, in particular, represents an emerging application of neuromodulation. According to the American Tinnitus Association, about 50 million people currently (2012) suffer from this disease in the U.S.

This report estimates the market for six major segments, namely, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcranial magnetic stimulation, and others. The report also estimates the market for different neuromodulation techniques as well as geographic analysis of each segment in North America, Europe, Asia-Pacific, and Rest of the World. As technologies develop and the number of trained physician increases, the likelihood of neuromodulation being seen as life-changing treatment will increase dramatically. It is estimated that the market for neuromodulation will be shared largely by deep brain stimulation and spinal cord stimulation.

The key players in the neuromodulation devices market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Enteromedics, Inc (U.S.), Neuropace, Inc (U.S.), Zynex, Inc (U.S.) and Neuronetics, Inc (U.S.). The emerging players in this market are Functional Neuromodulation, Ltd (U.S.), Microtransponder (U.S.), and Neurosigma, Inc (U.S.).

Scope of the Report

The research report categorizes the global neuromodulation devices market by procedure, technology, and application. These markets are broken down into segments and sub-segments, providing exhaustive value-volume analysis for 2010, 2011, and 2012 as well as forecast up to 2017. Each market is also analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World to provide in-depth information on the global scenario.

Global Neurostimulation Devices Market, by Procedure:

Internal Neurostimulation
Spinal Cord Stimulation (SCS)
Failed Back Surgery Syndrome
Chronic Pain
Ischemic Pain
Others
Deep Brain Stimulation (DBS)
Movement Disorders
Parkinson’s Disease
Alzheimer’s Disease
Dystonia
Tourette’s Syndrome
Others
Chronic Pain
Depression
Post-Traumatic Coma
Sacral Nerve Stimulation (SNS)
Urine Incontinence
Fecal Incontinence
Vagus Nerve Stimulation (VNS)
Epilepsy disease
Heart Failure
Tinnitus
Others
Gastric Electrical Stimulation (GES)
Gastroparesis
Others
External Neurostimulation
Transcranial Magnetic Stimulation (TMS)
Depression
Tinnitus
Migraine
Stroke
Others
Transcutaneous Electrical Nerve Stimulation (TENS)
Global Neurostimulation Devices Market, by Geography

North America
Europe
Asia-Pacific
Rest of the World

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION
1.1 KEY TAKE-AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 RESEARCH METHODOLOGY
1.4.1 MARKET SIZE
1.4.2 MARKET SHARE
1.4.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.4.4 KEY DATA POINTS FROM PRIMARY SOURCES
1.4.5 ASSUMPTIONS
1.5 STAKEHOLDERS

2 EXECUTIVE SUMMARY

3 MARKET OVERVIEW
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 MARKET DYNAMICS
3.3.1 DRIVERS
3.3.1.1 INCREASING INCIDENCE OF NEUROLOGICAL DISORDERS TO SPUR MARKET GROWTH
3.3.1.2 UNPRECEDENTED GLOBAL AGING TO FUEL MARKET GROWTH
3.3.1.3 STRONG PRODUCT PIPELINE TO PROPEL THE MARKET
3.3.1.4 EXPANDED TARGET APPLICATIONS AND NEW INDICATIONS ARE EXPECTED TO STIMULATE GROWTH OF NEUROMODULATION DEVICES
3.3.1.5 INVESTMENTS AND FUNDS – AN IMPETUS FOR MARKET GROWTH
3.4 RESTRAINTS
3.4.1.1 AN UNFAVOURABLE REIMBURSEMENT SCENARIO HINDERS MARKET GROWTH
3.4.1.2 LACK OF TRAINED PROFESSIONALS LIKELY TO HAMPER MARKET GROWTH
3.5 MARKET SHARE ANALYSIS

4 GLOBAL NEUROMODULATION MARKET (INTERNAL & EXTERNAL)
4.1 INTRODUCTION
4.2 INTERNAL STIMULATION
4.2.1 SPINAL CORD STIMULATION (SCS) MARKET
4.2.1.1 MAJOR APPLICATIONS
4.2.1.1.1 FAILED BACK SURGERY SYNDROME
4.2.1.1.2 CHRONIC PAIN
4.2.1.1.3 ISCHEMIA
4.2.2 DEEP BRAIN STIMULATION (DBS)
4.2.2.1 MAJOR APPLICATIONS
4.2.2.1.1 PARKINSON’S DISEASE
4.2.2.1.2 DYSTONIA
4.2.2.1.3 TREMOR
4.2.2.1.4 ALZHEIMER’S
4.2.3 SACRAL NERVE STIMULATION (SNS)
4.2.3.1 MAJOR APPLICATIONS
4.2.3.1.1 URINE INCONTINENCE
4.2.3.1.2 FECAL INCONTINENCE
4.2.4 VAGUS NERVE STIMULATION (VNS)
4.2.4.1 MAJOR APPLICATIONS
4.2.4.1.1 EPILEPSY
4.2.4.1.2 OTHERS
4.2.5 GASTRIC ELECTRICAL STIMULATION (GES)
4.3 EXTERNAL STIMULATION
4.3.1 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS)
4.3.2 TRANSCRANIAL MAGNETIC STIMULATION (TMS)

5 GEOGRAPHIC ANALYSIS
5.1 INTRODUCTION
5.2 NORTH AMERICA
5.3 EUROPE
5.4 ASIA
5.5 REST OF THE WORLD

6 COMPETITIVE LANDSCAPE
6.1 INTRODUCTION
6.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS & JOINT VENTURES
6.3 NEW PRODUCT LAUNCH
6.4 EXPANSION
6.5 OTHER DEVELOPMENTS
6.6 APPROVALS

7 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)*
7.1 ANM ADAPTIVE NEUROMODULATION GMBH
7.2 BIOCONTROL MEDICAL, LTD.
7.3 BOSTON SCIENTIFIC CORPORATION
7.4 CERBOMED GMBH
7.5 CYBERONICS, INC.
7.6 ENDOSTIM, INC.
7.7 ENTEROMEDICS, INC.
7.8 THE MAGSTIM COMPANY LIMITED
7.9 MEDTRONIC, INC.
7.10 NEURONETICS, INC.
7.11 NEUROPACE, INC.
7.12 NEUROSIGMA, INC.
7.13 NEVRO CORPORATION
7.14 RS MEDICAL
7.15 SPINAL MODULATION, INC.
7.16 ST. JUDE MEDICAL
7.17 SYNAPSE BIOMEDICAL, INC.
7.18 UROPLASTY, INC.
7.19 ZYNEX, INC.
*DETAILS ON FINANCIALS, PRODUCT & SERVICES, STRATEGY, AND DEVELOPMENTS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.

LIST OF TABLES

TABLE 1 GLOBAL NEUROMODULATION MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 2 GLOBAL NEUROMODULATION MARKET, BY MODALITY,2010 - 2017 ($MILLION)
TABLE 3 SCS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 4 SCS MARKET VOLUME, BY GEOGRAPHY,2010 - 2017 (NO OF UNITS)
TABLE 5 GLOBAL SCS MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 6 DBS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 7 DBS MARKET VOLUME, BY GEOGRAPHY,2010-2017 (NO OF UNITS)
TABLE 8 GLOBAL DBS MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 9 SNS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 10 SNS MARKET VOLUME, BY GEOGRAPHY,2010 - 2017 (NO OF UNITS)
TABLE 11 GLOBAL SNS MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 12 VNS MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 13 VNS MARKET VOLUME, BY GEOGRAPHY,2010 - 2017 (NO OF UNITS)
TABLE 14 GLOBAL VNS MARKET, BY APPLICATION,2010 - 2017 ($MILLION)
TABLE 15 GES MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 16 GES MARKET VOLUME,BY GEOGRAPHY, 2010 - 2017 (NO OF UNITS)
TABLE 17 GLOBAL GES MARKET,BY APPLICATION, 2010-2017 ($MILLION)
TABLE 18 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET,BY GEOGRAPHY, 2010 - 2017($MILLION)
TABLE 19 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET VOLUME, BY GEOGRAPHY, 2010 - 2017 (NO OF UNITS)
TABLE 20 TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 21 TRANSCRANIAL MAGNETIC STIMULATION MARKET VOLUME,BY GEOGRAPHY, 2010 - 2017 (NO OF UNITS)
TABLE 22 GLOBAL TRANSCRANIAL MAGNETIC STIMULATION MARKET,BY APPLICATION, 2010 - 2017 ($MILLION)
TABLE 23 NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY,2010 - 2017 ($MILLION)
TABLE 24 EXTERNAL NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 25 INTERNAL NEUROMODULATION DEVICES MARKET, BY GEOGRAPHY, 2010 - 2017 ($MILLION)
TABLE 26 GLOBAL EXTERNAL NEUROMODULATION MARKET, BY MODALITY,2010 - 2017 ($MILLION)
TABLE 27 GLOBAL EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO OF UNITS)
TABLE 28 NORTH AMERICA: NEUROMODULATION DEVICES MARKET,BY PROCEDURE, 2010 - 2017 ($MILLION)
TABLE 29 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 30 NORTH AMERICA: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 31 NORTH AMERICA: EXTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 32 NORTH AMERICA: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 33 NORTH AMERICA: SCS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 34 NORTH AMERICA: DBS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 35 NORTH AMERICA: SNS, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 36 NORTH AMERICA: VNS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 37 NORTH AMERICA: GES MARKET,BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 38 NORTH AMERICA: TMS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 39 NORTH AMERICA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 40 EUROPE: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 41 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 42 EUROPE: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 43 EUROPE: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 44 EUROPE: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME, BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 45 EUROPE: SCS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 46 EUROPE: DBS, BY REGION,2010 - 2017 ($MILLION)
TABLE 47 EUROPE: SNS, BY REGION,2010 - 2017 ($MILLION)
TABLE 48 EUROPE: VNS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 49 EUROPE: GES MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 50 EUROPE: TRANSCRANIAL MAGNETIC STIMULATION MARKET,BY REGION, 2010 - 2017 ($MILLION)
TABLE 51 EUROPE: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 52 ASIA: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 53 ASIA: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 54 ASIA: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 55 ASIA: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 56 ASIA: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 57 ASIA: SCS MARKET, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 58 ASIA: DBS MARKET, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 59 ASIA: SNS, BY COUNTRY,2010 - 2017 ($MILLION)
TABLE 60 ASIA: TMS MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 61 ASIA: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY COUNTRY, 2010 - 2017 ($MILLION)
TABLE 62 ROW: NEUROMODULATION DEVICES MARKET, BY PROCEDURE,2010 - 2017 ($MILLION)
TABLE 63 ROW: INTERNAL NEUROMODULATION DEVICES MARKET, BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 64 ROW: INTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 65 ROW: EXTERNAL NEUROMODULATION DEVICES MARKET,BY MODALITY, 2010 - 2017 ($MILLION)
TABLE 66 ROW: EXTERNAL NEUROMODULATION DEVICES MARKET VOLUME,BY MODALITY, 2010 - 2017 (NO. OF UNITS)
TABLE 67 ROW: SCS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 68 ROW: DBS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 69 ROW: SNS, BY REGION,2010 - 2017 ($MILLION)
TABLE 70 ROW: VNS MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 71 ROW: GES MARKET, BY REGION,2010 - 2017 ($MILLION)
TABLE 72 ROW: TRANSCRANIAL MAGNETIC STIMULATION MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 73 ROW: TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION MARKET, BY REGION, 2010 - 2017 ($MILLION)
TABLE 74 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, CONTRACTS & JOINT VENTURES, 2010 - 2012
TABLE 75 NEW PRODUCT LAUNCH, 2010 - 2012
TABLE 76 EXPANSION, 2010 - 2012
TABLE 77 OTHER DEVELOPMENTS, 2010 - 2012
TABLE 78 APPROVALS, 2010 - 2012
TABLE 79 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 80 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, 2009 - 2011 ($MILLION)
TABLE 81 BOSTON SCIENTIFIC: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 82 CYBERONICS, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 - 2011 ($MILLION)
TABLE 83 CYBERONICS, INC.: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 84 MEDTRONIC, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 - 2011 ($MILLION)
TABLE 85 MEDTRONIC, INC: TOTAL REVENUE, BY SEGMENTS,2009 - 2011 ($MILLION)
TABLE 86 MEDTRONIC, INC.: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 87 ST. JUDE MEDICAL, INC: TOTAL REVENUE AND R&D EXPENDITURE, 2009 - 2011 ($MILLION)
TABLE 88 ST. JUDE MEDICAL, INC: TOTAL REVENUE, BY SEGMENTS,2009 - 2011 ($MILLION)
TABLE 89 ST. JUDE MEDICAL, INC: TOTAL REVENUE, BY GEOGRAPHY,2009 - 2011 ($MILLION)
TABLE 90 UROPLASTY, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2010-2012 ($MILLION)
TABLE 91 UROPLASTY, INC.: TOTAL REVENUE, BY GEOGRAPHY,2010 - 2012 ($MILLION)
TABLE 92 ZYNEX, INC.: TOTAL REVENUE AND R&D EXPENDITURE,2009 - 2011 ($MILLION)
TABLE 93 ZYNEX, INC.: TOTAL REVENUE, BY SEGMENTS,2009 - 2011 ($MILLION)


LIST OF FIGURES

FIGURE 1 NEUROMODULATION MARKET SEGMENTATION
FIGURE 2 MARKET DYNAMICS
FIGURE 3 NEUROMODULATION MARKET SHARE ANALYSIS, BY REVENUE, 2011
FIGURE 4 KEY GROWTH STRATEGIES, 2010 - 2012

★調査レポート[世界の神経調節市場：脊髄刺激、迷走神経刺激など] ( Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017 / MD 1378) 販売に関する免責事項
[世界の神経調節市場：脊髄刺激、迷走神経刺激など] ( Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017 / MD 1378) についてEメールでお問い合わせ
◆関連調査資料◆
  • 椎弓根スクリューシステムの世界市場予測（～2023年）
    MD-6673 / MarketsandMarkets / 2018年10月11日 / MarketsandMarketsが発行した当調査レポートでは、椎弓根スクリューシステムの世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品タイプ別（単軸タイプ、多軸タイプ）分析、手術別（直視下手術、低侵襲手術）分析、適応症別（脊椎変形、脊椎外傷）分析、用途別（胸腰椎固定、頸椎固定）分析、椎弓根スクリューシステムの世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。...The global pedicle screw systems market is expected to reach USD 724.23 million by 2023 from USD 538.64 million in 2018, at a CAGR of 6.1%. The major factors driving the growth of this market are the increasing incidence of spinal cord injuries, the growing preference for minimally invasive surgeries, and a rising geriatric population. By product type, the pedicle screw systems market is segmented into monoaxial, polyaxial, and other pedicle screw systems. In 2018, the polyaxial pedicle screw systems segment is estimated to command the largest share of the pedicle screw systems market. The large share of this segment...

    • ◆H&Iグローバルリサーチ株式会社のお客様（例）◆